-
Arachidonic Acid as a Dietary Vaccine Adjuvant
2026-08-19
The reference study shows that dietary arachidonic acid can accelerate and strengthen rabies vaccine-induced humoral immunity in mice and human volunteers. Its mechanistic contribution is the identification of a lymph-node ARA–PGI2–cAMP–PKA pathway that enhances CD86 expression and activation-induced cytidine deaminase in B cells, supporting more effective germinal-center responses.
-
Oteseconazole (VT-1161) Assay Workflows
2026-08-18
Build reproducible Candida assays with Oteseconazole (VT-1161), from DMSO stock preparation through MIC testing and resistance-focused follow-up. Its selective fungal CYP51 mechanism, activity against fluconazole-resistant Candida, and transporter-aware profile support a more complete translational workflow than potency testing alone.
-
AMPK–SQSTM1 Feedback in Metabolic Stress
2026-08-18
The 2024 Autophagy study identifies a double-positive feedback loop in which AMPK and SQSTM1/p62 reinforce one another during metabolic stress, jointly activating AMPK and NFE2L2/NRF2 antioxidant defenses. Its mechanistic model connects lysosomal deacidification, TFEB/TFE3 regulation, ROS-dependent TAK1 activation, and p62 phosphorylation, offering a framework for understanding stress adaptation in STK11- and KEAP1-altered lung cancer.
-
Triamcinolone: Practical Research Workflow
2026-08-17
Triamcinolone (SKU B1859) is a synthetic glucocorticoid agonist for controlled in vitro studies of glucocorticoid signaling, inflammation, and immunosuppression. This guide focuses on solubilization, storage, assay controls, and QC while clarifying that the compound is for scientific research only and is not intended for diagnostic, therapeutic, or clinical use.
-
Berberrubine Chloride: Mechanism-to-Assay Guide
2026-08-17
Berberrubine chloride is a multi-target research compound whose value extends beyond generic cytotoxicity testing. This guide connects IMPDH2, TrxR, urate transport, and GSTM2 epigenetic biology to practical assay design for colorectal cancer research, urothelial carcinoma, NSCLC, and inflammation studies.
-
Dynamic Myelin Remodeling After CNS Damage
2026-08-16
A 2026 Science study shows that early CNS myelin damage is marked by swelling that can remodel and sometimes resolve rather than inevitably progressing to sheath loss. Across zebrafish, rodent, and human MS material, the work identifies neuronal activity as a modifiable factor that can worsen early pathology, creating a rationale for protecting compromised myelin before irreversible demyelination occurs.
-
Budesonide in Airway Inflammation Research
2026-08-15
Budesonide is a potent anti-inflammatory corticosteroid used to study glucocorticoid control of airway inflammation. Its rapid pulmonary absorption, low reported systemic bioavailability, defined solvent compatibility, and compatibility with biomimetic permeability workflows make it useful for respiratory disease research, while permeability-model results must not be treated as Budesonide-specific clinical evidence.
-
Hexose Diphosphate in Metabolic Inflammation
2026-08-14
Hexose diphosphate provides a water-compatible starting point for connecting glycolytic flux, ischemic energy failure, and inflammation-related assays. This practical guide separates validated product handling from hypothesis-generating workflows inspired by new evidence that phosphoenolpyruvate can restrain cGAS–STING inflammation during aging.
-
Berberine Hydrochloride Workflows for AKI Research
2026-08-14
Build reproducible Berberine hydrochloride workflows that connect AMPK-driven metabolic assays with mechanistic inflammation studies in acute kidney injury models. The guide emphasizes solvent control, pathway-resolved readouts, and cautious testing of whether berberine alters oxidized self-DNA, NLRP3, or A20-associated responses.
-
Methylprednisolone in Bone Loss Models
2026-08-13
Methylprednisolone helps researchers connect glucocorticoid-driven inflammation with osteoclast activity, making it useful for both cell-based screening and translational bone disease models. This workflow combines cytokine, signaling, histology, and micro-CT readouts while addressing solubility, vehicle, and model-consistency challenges.
-
Honokiol at the Immunometabolism–Inflammation Interface
2026-08-13
A translational framework for using Honokiol to interrogate the relationship between NF-κB signaling, oxidative stress, tumor angiogenesis, and the metabolic flexibility of antitumor CD8+ T cells.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-08-12
Saito and colleagues developed an accessible three-dimensional culture strategy for generating intestinal organoids from human induced pluripotent stem cells. The resulting organoids can be expanded, cryopreserved, and differentiated into intestinal epithelial cells with cytochrome P450 and transporter activities relevant to human pharmacokinetic studies.
-
Urolithin A: Designing Metabolic Fibrosis Assays
2026-08-12
Urolithin A can extend mitochondrial quality-control studies into more rigorous metabolic fibrosis assays. This article connects mitophagy biology with glutamine-dependent hepatic stellate-cell activation while separating established evidence from testable experimental hypotheses.
-
Ruthenium Red: A Causal Tool for Calcium Signaling
2026-08-11
Ruthenium Red is a Ca2+ transport inhibitor for separating calcium-dependent effects from cytoskeletal mechanotransduction and autophagy. This guide connects membrane transport biology with practical assay design, controls, and interpretation limits.
-
Sumatriptan Succinate in Translational Migraine Research
2026-08-11
Sumatriptan is more than a clinical migraine therapy: it is a receptor-defined tool for studying serotonergic signaling, neurovascular biology, and inflammation. This thought-leadership guide connects mechanism, assay design, metabolic considerations, and pediatric emergency-department evidence to help translational researchers use the compound with greater rigor.